- Acute Attacks: High-dose intravenous corticosteroids (like methylprednisolone) and sometimes plasma exchange.
- Long-term Management: Immunosuppressive drugs like corticosteroids, azathioprine, mycophenolate mofetil, and rituximab.
- FDA-approved Treatments: Soliris (eculizumab), Uplizna (inebilizumab-cdon), and Enspryng (satralizumab-mwge) for AQP4 antibody-positive patients.
- Symptom Management: Medications to control spasms and manage long-term muscle stiffness.